Business
AstraZeneca launches new drug to prevent COVID symptoms – Sydney Morning Herald
The company behind one of Australia’s key COVID-19 vaccines has filed for approval in the US for a drug to fight the virus.
Pfizer launched a study of the drug in 2,660 patients last week. Its treatment is designed as a pill that is taken over five days at the first sign of infection or awareness of exposure to the virus, acting to block the activity of the enzyme the virus…
Continue Reading
-
General20 hours agoLogies 2025 winners list: Lynne McGranger wins gold, Fisk sweeps comedy categories
-
General7 hours agoBali scooter crash victim Keanu Neilsen’s surgery could cost more than $100,000
-
General23 hours agoThe forgotten terms of good and evil
-
Business13 hours agoCan you guess which 2 Big 4 banks Macquarie prefers?